Tag: NSAIDs
Articles
News
- Aspirin use is associated with reduced risk of breast cancer, but ibuprofen may increase it
- Aspirin use reduces risk of all hormone receptor types of breast cancer
- Celebrex and other selective COX-2 inhibitors may reduce risk of breast cancer
- Cox-2 inhibitor fails to prevent progression from DCIS to breast cancer in mice
- Migraine sufferers have lower risk of ER+/PR+ tumors - implications for choice of treatment
- NSAID given during breast cancer surgery might reduce risk of recurrence
- Pain killers reduce circulating sex hormones
- Regular aspirin use may be associated with reduced risk of breast cancer
- Taking aspirin improves breast cancer survival
- Taking Celebrex might reduce the effectiveness of chemotherapy for breast cancer
- Use of aspirin and other NSAIDs before diagnosis does not improve breast cancer survival
Studies
- Analgesic Use and Sex Steroid Hormone Concentrations in Postmenopausal Women
- Antibiotic Use in Relation to the Risk of Breast Cancer
- Aspirin and Other Nonsteroidal Anti-inflammatory Drugs and Breast Cancer Incidence in a Large U.S. Cohort
- Aspirin Intake and Survival After Breast Cancer
- Aspirin use and breast cancer risk: a meta-analysis
- Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ Diagnosis
- Cyclooxygenase-2 Inhibition for the Prophylaxis and Treatment of Preinvasive Breast Cancer in a Her-2/Neu Mouse Model
- Do Intraoperative Analgesics Influence Breast Cancer Recurrence After Mastectomy? A Retrospective Analysis
- Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study
- Effect of red clover isoflavones on cox-2 activity in murine and human monocyte/macrophage cells
- Interaction of celecoxib with different anti-cancer drugs is antagonistic in breast but not in other cancer cells
- Migraine History and Breast Cancer Risk Among Postmenopausal Women
- Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype
- Nonsteroidal Anti-Inflammatory Drug Use and Breast Cancer Risk by Stage and Hormone Receptor Status
- Nonsteroidal Anti-Inflammatory Drugs and Risk for Ovarian and Endometrial Cancers in the Iowa Women's Health Study
- NSAID Analgesic Ketorolac Used Perioperatively May Suppress Early Breast Cancer Relapse: Something for Nothing in Breast Cancer?
- Perioperative Use of β-blockers and COX-2 Inhibitors May Improve Immune Competence and Reduce the Risk of Tumor Metastasis
- Relationship between Migraine History and Breast Cancer Risk among Premenopausal and Postmenopausal Women
- Selective cyclooxygenase-2 (COX-2) inhibitors and breast cancer risk
- Systematic Analyses of Genes Associated with Radiosensitizing Effect by Celecoxib, a Specific Cyclooxygenase-2 Inhibitor
- Use of non-steroidal anti-inflammatory drugs and survival following breast cancer diagnosis
- Use of Nonsteroidal Anti-inflammatory Drugs and Survival Following Breast Cancer Diagnosis